Brevan Howard Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$228K Buy
+9,290
New +$220K ﹤0.01% 1812
2025
Q3
Sell
-11,140
Closed -$277K 2345
2025
Q2
$277K Buy
+11,140
New +$314K ﹤0.01% 1584
2025
Q1
Sell
-15,706
Closed -$495K 1529
2024
Q4
$495K Buy
+15,706
New +$746K ﹤0.01% 625

Other funds holding ASTH

Brevan Howard Capital Management's ASTH Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Astrana Health (ASTH) in Q1 2026: 9,290 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #1812 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in ASTH as recently as Q2 2025.

Brevan Howard Capital Management first reported a position in ASTH in Q4 2024 and has held it in 3 quarters since. The position peaked at $495K in Q4 2024. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Brevan Howard Capital Management held 9,290 shares of Astrana Health worth $228K as of Q1 2026.
  • Astrana Health was a new Brevan Howard Capital Management position in Q1 2026.
  • Astrana Health made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1812 holding.
  • Brevan Howard Capital Management first reported a position in Astrana Health in Q4 2024 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's Astrana Health position peaked at $495K in Q4 2024.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.